Corticosteroids Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The corticosteroids market is segmented by Product type (Glucocorticoids, Mineralocorticoids), Route of Administration (Topical steroids, Inhaled steroids, Oral forms, Systemic forms), Application type and Geography.

Corticosteroids Market Snapshot

Corticosteroids Market snapshot
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4.3 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The corticosteroids market is expected to witness a CAGR of 4.3%, during the forecast period (2020-2025). The major factors accounting for the growth of the corticosteroid market are increasing the incidence of chronic diseases, growing geriatric population and surging investment in research and development. According to the United Nations forecast human population is expected to increase from 7.2 billion today to 8.2 billion by 2025. This, in turn, increases the burden of chronic diseases to 57% worldwide according to WHO by the end of 2020 and is expected to increase further during the forecast period. Hence, this uninterrupted incidence and prevalence of chronic diseases lead to the growth of the Corticosteroids market during the forecast period. However, the risk factors associated with the prolonged use of corticosteroids hampers the growth of the market to some extent.

Scope of the Report

Corticosteroids are the steroid hormones that are either produced by the body (Systemic corticosteroids) or man-made (Synthetic corticosteroids). When the adrenal cortex ceases the production of required corticosteroids, synthetic corticosteroids are given to the patients. They are often used as part of treatment for different diseases like asthma, various skin allergies, arthritis among others.

By Product
Glucocorticoids
Mineralocorticoids
By Route of administration
Topical steroids
Inhaled steroids
Oral forms
Systemic forms
Others
By Application
Rheumatology indications
Skin allergies
Endocrinology
Gastroenterology
Acute respiratory diseases
Others
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Topical Steroids segment by Route of Administration Dominates the Market

Topical steroids are used in treating the skin conditions such as rash, dermatitis, itching, eczema, and psoriasis and this segement is expected to dominate the market due to the continuous growth of the geriatric population with rising skin diseases around the world and the extended storage capacity of the topical corticosteroids. As aging results in the decline of the normal functioning of organ systems including skin, the geriatric population is highly prone to skin diseases. According to the data from World Population Prospects: the 2019 Revision, by 2050, one in six people in the world will be over age 65 (16%), up from one in 11 in 2019 (9%). In terms of convenience, the geriatric population with skin diseases prefers to use topical steroids. All these factors together support that Topical steroids dominate the corticosteroids market.

corticosteroids market

North America Dominates the Market and the Same is Expected Over the Forecast Period.

North America is expected to dominate the overall market, throughout the forecast period, which is attributed to the developed economy, increasing health care expenditure, increasing incidence of lifestyle-related diseases and high adoption of technologically advanced products in the region. According to National Cancer Institute statistics the incidence of cancer increased to 1.8 million in 2019 from 1.73 million in 2018, suggests the growth in chronic diseases burden in United States. Furthermore, according to the World Population Prospects: the 2019 Revision, one in four persons living in North America could be aged 65 or over by 2050 which strongly supports North America to dominate the market during the forecast period.

corticosteroids market

Competitive Landscape

The corticosteroids market is moderately competitive and consists of several major players. With the increasing consolidations of various organizations in the healthcare sector, it is expected to generate the competitive rivalry among the key players in future. Some of the major players of the market are Pfizer Inc., Novartis, AstraZeneca, GSK, Cipla Inc., and Merck etc.,

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Geriatric Population and Increasing Incidence of Chronic Diseases

      2. 4.2.2 Surging investment in Research and Development

    3. 4.3 Market Restraints

      1. 4.3.1 Pricing Pressure on the Companies by the Government

      2. 4.3.2 Risk factors associated with Corticosteriods on Prolonged use

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Glucocorticoids

      2. 5.1.2 Mineralocorticoids

    2. 5.2 By Route of administration

      1. 5.2.1 Topical steroids

      2. 5.2.2 Inhaled steroids

      3. 5.2.3 Oral forms

      4. 5.2.4 Systemic forms

      5. 5.2.5 Others

    3. 5.3 By Application

      1. 5.3.1 Rheumatology indications

      2. 5.3.2 Skin allergies

      3. 5.3.3 Endocrinology

      4. 5.3.4 Gastroenterology

      5. 5.3.5 Acute respiratory diseases

      6. 5.3.6 Others

    4. 5.4 By Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Pfizer Inc.

      2. 6.1.2 Novartis AG

      3. 6.1.3 Sanofi S.A.

      4. 6.1.4 GlaxoSmithKline plc

      5. 6.1.5 Cipla Inc.

      6. 6.1.6 Johnson & Johnson Services, Inc.

      7. 6.1.7 AstraZeneca plc

      8. 6.1.8 Merck & Co., Inc.,

      9. 6.1.9 Sumitomo Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Corticosteroids Market market is studied from 2018 - 2026.

The Corticosteroids Market is growing at a CAGR of 4.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Pfizer Inc. , Novartis, GSK, Merck, AstraZeneca are the major companies operating in Corticosteroids Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!